GreenLight Biosciences Holdings, PBC Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRNAW and buy or sell other stocks, ETFs, and their options commission-free!About GRNAW
GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. Its breakthrough biomanufacturing platform is engaged in discovering, developing, scaling, and commercializing RNA solutions at volume across multiple sectors in the agricultural and human health markets.
CEOAndrey J. Zarur, PhD
CEOAndrey J. Zarur, PhD
Employees—
Employees—
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2020
Founded2020
Employees—
Employees—
GRNAW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume183.66K
Average volume183.66K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.6971
52 Week high$0.6971
52 Week low$0.0062
52 Week low$0.0062
Stock Snapshot
GreenLight Biosciences Holdings, PBC Warrant(GRNAW) stock is priced at $0.02.
On 2025-12-08, GreenLight Biosciences Holdings, PBC Warrant(GRNAW) stock opened at —, reached a high of —, and a low of —.
The GreenLight Biosciences Holdings, PBC Warrant(GRNAW)'s current trading volume is 0, compared to an average daily volume of 183.66K.
In the last year, GreenLight Biosciences Holdings, PBC Warrant(GRNAW) shares hit a 52-week high of $0.70 and a 52-week low of $0.01.
In the last year, GreenLight Biosciences Holdings, PBC Warrant(GRNAW) shares hit a 52-week high of $0.70 and a 52-week low of $0.01.